Skip to main content
. 2024 Feb 28;21(2):219–231. doi: 10.26599/1671-5411.2024.02.002

Table 3. Pleiotropy testing of plasma metabolites (exposure) and myocardial infarction (outcome).

Exposure ID Traits Outcome Egger intercept P-value
GCST90199705 Propionylglycine levels Myocardial infarction 0.007 0.323
GCST90199741 Gamma-glutamylglycine levels Myocardial infarction 0.006 0.282
GCST90199807 Hexadecanedioate (C16-DC) levels Myocardial infarction 0.004 0.398
GCST90200054 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels Myocardial infarction 0.006 0.257
GCST90200059 Behenoyl dihydrosphingomyelin (d18:0/22:0) levels Myocardial infarction 0.007 0.467
GCST90200065 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels Myocardial infarction 0.006 0.333
GCST90200259 Pentose acid levels Myocardial infarction 0.007 0.131
GCST90200438 Alpha-ketobutyrate levels Myocardial infarction 0.007 0.387
GCST90200630 X-24546 levels Myocardial infarction 0.005 0.873
GCST90200680 5-acetylamino-6-formylamino-3-methyluracil levels Myocardial infarction 0.005 0.311
GCST90200707 Glycine levels Myocardial infarction 0.003 0.206
GCST90200726 N-acetylputrescine to (N (1) + N (8))-acetylspermidine ratio Myocardial infarction 0.004 0.058
GCST90200758 Glycine to serine ratio Myocardial infarction 0.005 0.505
GCST90200782 Mannose to trans-4-hydroxyproline ratio Myocardial infarction 0.007 0.783